Update On Dicom Imaging Systems Update On Dicom Imaging Systems 
WESTON, FL -- (INTERNET WIRE) -- 03/16/00 -- Update on
Dicom Imaging Systems  (OTCBB: DCIM) with a price target of $60 per
Dicom Imaging Systems, Inc. (OTC BB:  DCIM)'s  imagEXPLORER has just
received it's first  upgrade.  The new D-Link feature, allows
virtually all Microsoft (NASDAQ: MSFT) Windows  based Dental Practice
Management software to be  successfully bridged with the Dicom
D-Link is a new feature upgrade to imagEXPLORER  that allows the user to
quickly retrieve patient  based information and data elements such as
name,  address, unique number etc. from virtually any  Windows based
patient management application.  This feature allows the customer to
automatically  create the patient file in imagEXPLORER. 
CRG feels the stock is a great buy, currently  trading at around the
25.00 range. CRG is  currently performing an intense public relations
campaign to alert new, experienced investors of  this opportunity.
CRG feels that the stock could  be trading around the $60 mark within
the next  few months. 
The company also recently announced that they  will receive a piece of
about 400 million claims  with an excess of $75 billion dollars. 
We are expecting an approximate number to be  released soon by the
company however we feel that  based on the current limited number of
shares  outstanding (about 7.2 million) and this recent  development
that this justifies out new price  target on DCIM. 
Remember also that DCIM has declared a 3 for 1  stock split for
shareholders of record at the  close of business on March 31, 2000.
DCIM also  plans to file for NASDAQ this April 2,000. 
The NASDAQ's Largest Volume Leaders. 
Applied Digital Solutions (NASDAQ: ADSX),  Epimmune Inc (NASDAQ: EPMN),
Smurfit-Container Cp  (NASDAQ: SSCC), Sovereign Bancorp,Inc (NASDAQ:
SVRN), Value America Inc (NASDAQ: VUSA),  Cytotherapeutics, Inc
(NASDAQ: CTII), Sunglass  Hut Int'l, Inc (NASDAQ: RAYS), Intl
Inc  (NASDAQ: BIDS), Aetrium, Inc (NASDAQ: ATRM),  Ravisent Tech Inc
About, a wholly owned online asset of  Capital Research Group,
Inc. was developed solely  for experienced, risk tolerant investors.
Subscribers to receive daily market  commentary reports
for select companies trading  on various markets.   Sophisticated
investors are  also able to receive for free, select, rare  research
reports and investor kits on up and  coming emerging companies while
they are still  not widely known. 
About Capital Research Group Inc. 
Through, Capital Research Group  (CRG) introduces
fundamentally sound, undervalued  companies to the investment
community.  Capital  Research Group strives to locate companies with
enormous growth potential.  CRG is a full service  public relations /
Investor relations firm.  For  more information about our products or
services,  please contact CRG at 954-217-9555 or visit us at 
All material herein was prepared by Capital  Research Group Inc. (CRG)
based upon information  supplied by the company or other sources
believed  to be reliable. The information contained herein  is not
guaranteed by CRG to be accurate, and  should not be considered to be
all-inclusive. The  companies that are discussed in this report, have
not approved the statements made in this report.  This discussion
contains forward-looking  statements that involve risks and
uncertainties.  A company's actual results could differ  materially
from those described in any forward- looking statements or announcements
discussed  within. This material is for information purposes  only and
should not be construed as an offer or  solicitation of an offer to
buy or sell the  securities. CRG is not a licensed broker, broker
dealer, market maker, investment banker,  investment advisor, analyst
or underwriter.  Please consult a broker before purchasing or  selling
any securities viewed on CRG has been compensated
by  one or more of the companies listed herein  (90,000 DCIM) for the
preparation and  distribution of this report. Much of this report  was
derived from a paid report written by  National Capital Securities
Research.  CRG, its  affiliates, and/or its officers, directors and
employees may buy, sell or have a position in the  securities
discussed in this report and may  profit in the event the shares of
the companies  discussed in this report rise in value. For  additional
information visit or call Capital research
Group Inc. direct. 
Contact: Charles  T. Tamburello, Capital Research Group Inc
Phone: 954-217-9555
Fax: 954-389-5756
 Provider ID: 02006633
Press spacebar to pause and continue. Press esc to stop.